Hypoxic VDAC1: A potential mitochondrial marker for cancer therapy

Advances in Experimental Medicine and Biology

Volumn 772, Issue , 2014, Pages 101-110

  Brahimi Horn, M Christiane ^a,b   Mazure, N M ^a  

^a UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Cancer cell; Chemoresistance; Hypoxia; Mitochondria; VDAC1

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE DEHYDROGENASE; VOLTAGE DEPENDENT ANION CHANNEL 1;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER STAGING; CANCER THERAPY; CONFERENCE PAPER; HUMAN; HYPOXIA; ION TRANSPORT; LUNG CANCER; MEMBRANE MARKER; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; CELL HYPOXIA; HUMANS; MITOCHONDRIA; NEOPLASMS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84934436478     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5915-6_5     Document Type: Conference Paper

References (35)

1. Andersson SG, Karlberg O, Canback B, Kurland CG (2003) On the origin of mitochondria: a genomics perspective. Philos Trans R Soc Lond B Biol Sci 358:165-177, discussion 77-79
2. Arbel N, Ben-Hail D, Shoshan-Barmatz V (2012) Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J biol chem 287:23152-23161
3. Bathori G, Parolini I, Szabo I, Tombola F, Messina A, Oliva M et al (2000) Extramitochondrial porin: facts and hypotheses. J Bioenerg Biomembr 32:79-89
4. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J et al (2009) Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29:2570-2581
5. Berridge M V, Herst PM, Lawen A (2009) Targeting mitochondrial permeability in cancer drug development. Mol Nutr Food Res 53:76-86
6. Brahimi-Horn MC, Laferrière J, Mazure N, Pouysségur J (2007a) Hypoxia and tumour progression. In: Marmé D, Fusenig N (eds) Tumor angiogenesis. Springer, Berlin/New York, pp 171-194
7. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007b) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19:223-229
8. Brahimi-Horn MC, Ben-Hail D, Ilie M, Gounon P, Rouleau M, Hofman V et al (2012) Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. Cancer Res 72:2140-2150
9. Brooks C, Dong Z (2007) Regulation of mitochondrial morphological dynamics during apoptosis by Bcl-2 family proteins: a key in Bak? Cell Cycle 6:3043-3047
10. Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouyssegur J, Mazure NM (2010) Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol 222:648-657
11. De Pinto V, Messina A, Lane DJ, Lawen A (2010) Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS lett 584:1793-1799
12. Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425-434
13. Fogg VC, Lanning NJ, Mackeigan JP (2011) Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer 30:526-539
14. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang C V, Semenza GL (2007) HIF-1 regulates cyto-chrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111-122
15. Galluzzi L, Kepp O, Kroemer G (2012a) Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13:780-788
16. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G (2012b) Mitochondrial control of cellular life, stress, and death. Circ Res 111:1198-1207
17. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891-899
18. Mathupala SP, Ko YH, Pedersen PL (2006) Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25:4777-4786
19. Mathupala SP, Ko YH, Pedersen PL (2010) The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta 1797:1225-1230
20. Palmer CS, Osellame LD, Stojanovski D, Ryan MT (2011) The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 23:1534-1545
21. Pedersen PL (2007) The cancer cell's "power plants" as promising therapeutic targets: an overview. J Bioenerg Biomembr 39:1-12
22. Pedersen PL (2008) Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer. J Bioenerg Biomembr 40:123-126
23. Penso J, Beitner R (1998) Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells. Eur J Pharmacol 342:113-117
24. Rolland SG, Conradt B (2010) New role of the BCL2 family of proteins in the regulation of mito-chondrial dynamics. Curr Opin Cell Biol 22:852-858
25. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491:364-373
26. Shoshan-Barmatz V, Israelson A (2005) The voltage-dependent anion channel in endoplasmic/sarcoplasmic reticulum: characterization, modulation and possible function. J Membr Biol 204:57-66
27. Shoshan-Barmatz V, Mizrachi D (2012) VDAC1: from structure to cancer therapy. Front Oncol 2:164
28. Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N (2010) VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31:227-285
29. Tondera D, Grandemange S, Jourdain A, Karbowski M, Mattenberger Y, Herzig S et al (2009) SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J 28:1589-1600
30. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033
31. Warburg O (1928) The chemical constitution of respiration ferment. Science 68:437-443
32. Wenner CE (2012) Targeting mitochondria as a therapeutic target in cancer. J Cell Physiol 227: 450-456
33. Youle RJ, van der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337: 1062-1065
34. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71
35. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB et al (2008) Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283: 10892-10903